Zimmerman Mark, Chelminski Iwona, Young Diane, Dalrymple Kristy, Walsh Emily, Rosenstein Lia
146 West River St, Providence, RI 02904
J Clin Psychiatry. 2014 Jun;75(6):601-7. doi: 10.4088/JCP.13m08961.
To acknowledge the clinical significance of anxiety in depressed patients, DSM-5 included criteria for an anxious distress specifier for major depressive disorder. In the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project, we modified our previously published depression scale to include a subscale assessing the DSM-5 anxious distress specifier.
From December 1995 to August 2013, 773 psychiatric outpatients with major depressive disorder completed the Clinically Useful Depression Outcome Scale (CUDOS) supplemented with questions for the DSM-5 anxious distress specifier (CUDOS-A). To examine discriminant and convergent validity, the patients were rated on clinician severity indices of depression, anxiety, and irritability. Discriminant and convergent validity was further examined in a subset of patients who completed other self-report symptom severity scales. Test-retest reliability was examined in a subset who completed the CUDOS-A twice. We compared patients who did and did not meet the DSM-5 anxious distress specifier on indices of psychosocial functioning and quality of life.
The CUDOS-A subscale had high internal consistency and test-retest reliability; was more highly correlated with other self-report measures of anxiety than with measures of depression, substance use problems, eating disorders, and anger; and was more highly correlated with clinician severity ratings of anxiety than depression and irritability. CUDOS-A scores were significantly higher in depressed outpatients with a current anxiety disorder than in depressed patients without a comorbid anxiety disorder (P < .001). Finally, patients who met the DSM-5 anxious distress specifier reported poorer psychosocial functioning and quality of life than patients who did not meet the anxious distress specifier.
In the present study of a large sample of psychiatric outpatients, the CUDOS-A was a reliable and valid measure of the DSM-5 anxious distress specifier for major depressive disorder.
为认识到焦虑在抑郁症患者中的临床意义,《精神疾病诊断与统计手册》第5版(DSM - 5)纳入了重度抑郁症的焦虑痛苦特征说明标准。在罗德岛改善诊断评估与服务方法(MIDAS)项目的本报告中,我们对之前发表的抑郁量表进行了修改,纳入了一个评估DSM - 5焦虑痛苦特征说明标准的分量表。
1995年12月至2013年8月,773名患有重度抑郁症的精神科门诊患者完成了临床有用的抑郁结局量表(CUDOS),并补充了关于DSM - 5焦虑痛苦特征说明标准的问题(CUDOS - A)。为检验区分效度和聚合效度,根据临床医生对抑郁、焦虑和易怒程度的评定对患者进行评分。在完成其他自我报告症状严重程度量表的部分患者中进一步检验区分效度和聚合效度。在完成CUDOS - A两次的部分患者中检验重测信度。我们比较了符合和不符合DSM - 5焦虑痛苦特征说明标准的患者在心理社会功能和生活质量指标方面的差异。
CUDOS - A分量表具有较高的内部一致性和重测信度;与其他焦虑自我报告测量方法的相关性高于与抑郁、物质使用问题、饮食失调和愤怒测量方法的相关性;与临床医生对焦虑严重程度的评定相关性高于对抑郁和易怒的评定。目前患有焦虑症的抑郁门诊患者的CUDOS - A得分显著高于无共病焦虑症的抑郁患者(P <.001)。最后,符合DSM - 5焦虑痛苦特征说明标准的患者报告的心理社会功能和生活质量比不符合焦虑痛苦特征说明标准的患者更差。
在本项对大量精神科门诊患者的研究中,CUDOS - A是用于评估重度抑郁症DSM - 5焦虑痛苦特征说明标准的可靠且有效的测量工具。